text:
fabian.consiglio got their new logo design by running a design contest:
Rebranding of Heaven Hound - Cargo Van Rental
Check out fabian.consiglio's Logo design contest…
We rent light commercial vehicles mostly to private customers for their move or simply to transport something big. Our customers are young and we treat these easy and straightforward. However, we also have corporate clients. Take a look at our actual logo and our flagship rental station pic lower on this site. For understanding how we do our business visit: https://www.heavenhound.ch Magyar Vizsla is our favorite breed of dog. Just an advice for a less aggressive dog shape.
Logo types to explore
Make it better than our actual logo.
Every design category has flexible pricing for all budgets. Logo design starts at HK$2,399.
Full copyright with production-ready files for digital and/or print.
It all began with a design brief.
A quick, interactive guide helped them understand their design style and captured exactly what they needed in their logo design.
Designers across the globe delivered design magic.
fabian.consiglio collaborated with designers to refine their ideas
When design entries come in, you can rate them so designers know what you’re looking for in your logo design.
99designs has great collaboration tools so you can pinpoint and capture your ideas
And then… they selected a winner!
Miljan provided great creative insight and quick iteration through the entire engagement. I'll encourage Miljan to participate in future work we do on 99d in the future.
Along the way, they met lots of talented designers…
We think contests are a super fun way to get design.
Recently completed contests:
We are a modern car company. Diagnosis is our specialty. also maintenance and occasion / sale cars.
We are a Wholesale company for car paint and other auto repair shop related products. We want to perceived as a trustwor
Automotive Repair for all Japanese makes and models along with all makes and models of hybrid vehicles
we specialize in vehicle impoundment and towing...
We are a car repair shop providing the best service in town! Our target audience is of all ages from young to old, and w


A new era has begun in e-Government! Citizens flocked
While getting tired of hundreds of notifications sent to the citizens' phones and e-mails, the Message Management System was put into use on the web, e-Government and mobile application as of January 7. While people who wanted to get rid of unsolicited messages were stunned to see the number of service providers allowed to send them, they chose to revoke most permissions.
While a message, a phone call, or both can be canceled by entering the IMS, companies must stop sending commercial electronic messages within three business days following the notification of rejection. For those who do not abide by this period, a complaint section will be opened on the site. However, this process will start after the end of the 45-day control and change period.
After February 16, citizens will be able to complain about companies that continue to send them advertisements despite the cancellation of the notification, by filling out the form and again on the site.
750 THOUSAND PEOPLE TRANSACTIONED
With the system established by TOBB, citizens can get rid of the messages of the companies they do not want in a simple and practical way. According to the information obtained, 750 thousand people in 5 days entered the Citizen.iys.org.tr system and changed the permission data of nearly 14 million. Thus, each person made changes in an average of 19 leaves.
Authorities drew attention to the fact that this number will grow even more in the coming days with the recognition of the İYS. While the citizen saw that some companies were not on the list when he entered the İYS, the authorities stated that the system currently includes companies with more than 150 thousand commercial electronic message approvals. The deadline for other companies with less than 150 thousand approvals to register in the IYS was determined as May 31, 2021. Thus, citizens will be able to see these companies on the IMS screen as of June 1, 2021. All natural and legal persons who want to send commercial messages, that is, to market via phone or SMS, e-mail, have to register with the IMS system. These persons and companies will not be able to send audio, written electronic messages to any citizen who does not have an IMS approval.


Iron Cross (also called IC) is arguably Myanmar’s most beloved rock band. Certainly it may be the oldest having started in the early 1990’s playing Van Halen songs. Since then they have moved to original content and consequently gained a worldwide following after completion of tours in Europe, the US, South Korea and Singapore. In 2008, following Cyclone Nargis, they played one of the largest rock concerts ever held in Myanmar by performing in front of 50,000 fans at a fundraiser at Thuwanah Sports Stadium in Yangon. More recently, they performed at People Park in Yangon at the Love & Rocks concert on February 9, 2014. Iron Cross is currently putting out a 20th anniversary album that is a compilation of their greatest hits over the last two decades.


Belford Parish Council is calling for counters monitoring traffic movement along the U34 Detchant road to stay in situ for at least a month.
Traffic counters have been placed on U34 to monitor the movement of articulated lorries travelling to Bedmax, which residents say are making their lives a misery.
The road has deteriorated in recent years due to the constant stream of HGVs carrying timber to the industrial plant, which produces horse bedding.
Northumberland County Council put traffic counters there earlier this month. But some Detchant residents have raised concerns that the number of HGVs travelling on the U34 to Detchant had significantly decreased since the counters were installed.
One resident told Belford Parish Council: “Last week when the counters went down there was a definite running down of traffic movement.”
He said the stock pile of wood at Bedmax had greatly diminished in recent weeks, and added: “I’m concerned as to whether the county council are getting a true representation.”
Chairing the discussion, Parish Council vice chair Geoff O’Connell said: “I think we should write to the county council and ask that the counters remain in place for a minimum of a month, in order to get as accurate a picture as possible.”


text:
Is Eating Green Apples Good During Pregnancy?
The idiom of apples and doctors has been as old as the beginning of time. In the same vein, many women tend to talk about consuming green apples during pregnancy as a wonderfully healthy option. Opting for green apple juice during pregnancy is also a decision taken by many pregnant mothers, and it just goes to show how wonderful it is to have them when pregnant. However, that should also come with some precautionary measures.
Nutritional Value of Green Apples
The nutrition that green apples provide spans from numerous vitamins to minerals and other healthy constituents.
|Vitamin C||5 mg|
|Vitamin A||5 mg|
|Pantothenic acid||60 mg|
|Folic acid||5 mg|
Surprising Benefits of Having Green Apples in Pregnancy
With a number of healthy substances present in green apples, the benefits they provide are surprisingly widespread and affect various areas of the body.
1. Increase in Energy
A lot of nutrients are sucked from the woman’s body throughout pregnancy for the baby’s benefit as well as other activities. This also manifests in the form of poor skin health, even causing acne at times. Green apples help provide the necessary energy back to the body and restore it all to normalcy.
2. Numerous Antioxidants
When any toxic materials or chemicals are formed in the body due to free radicals or breakdown of DNA, these need to be kept away from healthy parts of the body using antioxidants. Green apples provide these antioxidants in substantial quantities in the forms of flavonoids and polyphenols. All of these reduce the stress of oxidation experienced by the body.
3. Better Digestion
Pregnant women are often tired of experiencing constipation throughout their journey. Most of the times, this is primarily due to the absence of fibre in their diet. Recurrent constipation can be harmful to the developing baby, too. That is why consuming green apples is important as it helps in stimulating bowel movements and streamlining digestion.
4. Reduced Swelling
The swelling of feet and legs is experienced by many women throughout pregnancy, which can get quite discomforting and painful at times. Green apples are rich in vitamin C that acts as an antioxidant and can help ease the swelling and bring much-needed relief.
5. Appetite Increase
Although a lot of energy is lost, at times, the appetite of a pregnant woman can take a hit. The absence of nourishment can be harmful to the baby since it requires regular and healthy meals throughout. Having some green apple juice has shown signs of restoring the appetite in women.
6. Treating Nausea
The stomach bears the highest brunt in pregnancy since the inner lining gets sensitive to acids. This primarily results in a vomiting sensation throughout. Green apples are sweet and sour to taste, which helps reduce the feeling of nausea when pregnant.
7. Diabetes Control
Many women experience pregnancy-induced diabetes which can cause adverse effects to the baby as well as the mother. Green apples can help in maintaining the right levels of insulin in the body. They contain fibre that provides a satiety value and hence helps lower sugar levels and control diabetes.
8. Reduced Premature Delivery Risks
At times, certain pregnant mothers do have conditions where their bodies secrete an unusually high level of bile. These can, at times, trigger labour pains, causing a premature delivery. Green apples help keep the bile secretion in check and reduce the risk of premature delivery.
9. Body Weight Regulation
Gaining weight during pregnancy is a sign of proper development, but that should be within healthy limits. Hypertension and high cholesterol can be a result of obesity and cause diabetes, too, making it difficult for the baby. Green apples not only help keep blood pressure in check, but their calorie count is low, which assists in weight control, too.
10. Protection for DNA
When free radicals are formed in the body, these begin attacking DNA molecules, many of which are responsible for the development of the foetus. Vitamin C and antioxidants present in green apples not only boost the formation of new cells but combat free radicals, protecting the DNA from breaking down.
Side Effects of Consuming Excessive Amount of Green Apples while Pregnant
The very qualities that make green apples a great fruit to be consumed in certain circumstances can deem it harmful to be consumed by others.
1. A Propensity for Weight Loss
Being overweight is definitely a problem, no doubt. The complications that obesity can bring to the pregnancy, as well as the health of the baby and the mother are far more dangerous than anything else. However, a mother does need to maintain an optimal weight to be able to carry the pregnancy full-term.
If the consumption of green apples is way beyond normal, it can cause rapid weight loss which can deem quite harmful for the pregnancy and lead to an underdeveloped child. A pregnant woman must eat green apples in small quantities as it will not lead to weight loss.
2. The Absence of Requisite Calories
Calories are the very source of powering various metabolic activities. Green apples do contain a lot of proteins that are beneficial for foetal growth, but the calorie count is less. This could make you feel full but not give you enough energy, leading to fatigue. Therefore, green apples need to be complemented by food items that are rich in calories.
Are Green Apples Better Than Red Apples?
Women often wonder if they can opt for red apples instead of green apples or do green apples provide an edge over the red ones.
- When it comes to controlling diabetes, green apples are your best bet.
- In times when your skin has lost its sheen and health, green apples can help bring it back to a healthy state.
- Both red and green apples work towards protecting the DNA molecules from breaking down.
- Appetite reduction can be restored almost easily by eating green apples.
No matter what trimester of pregnancy you are in, having green apples can be extremely beneficial to the growth of the baby. As always, keep things in moderation to reap the best benefits from it so that your baby grows fully and you have a wonderful natural delivery at the end.

domain: biology


text:
Technically, carbon transfer printing isn’t ‘carbon’ anymore once it becomes color. Yes, for the black/key layer (if used), a carbon pigment is generally used. But for the other colors, evidently carbon falls short. So something like ‘pigmented gelatin printing’ is more accurate. In any case, as color enters, it brings many questions, issues and concerns. Lots of fun stuff, as well. How about this one: which colors should we go for in the first place? Let’s have a look and see if we can make at least a first step.
The elephant in the room, let’s start with that. It’s big. And it’s pink. Or at least, it’s supposed to be, but it doesn’t quite render the correct shade of pink. Cue a drum roll, because here are my first ever color carbon prints, and you’ll immediately recognize the need for this blog post:
The torture test appears to work as intended. It’s pure torture, horror and Spanish inquisition all over. Well, it’s certainly clear that there are some, ehm, minor issues to be ironed out. But given this dramatic success, I thought I’d try an actual photograph. Truth be told, I used my second set of color tissues to make the color checker and had exactly one set left I didn’t really need for other tests, so I figured, why not try an actual print and see how bad it comes out. Well, pretty bad, I can tell you that! Here, look:
You know, I’m actually quite happy with it! I mean, it’s sort of recognizable as the same image. It also materialized without too many difficulties; there were no blatant transfer issues, and the printing process was fairly swift. I made the actual prints within an hour or so, not counting the tissue drying time and the time to transfer each individual print onto the final support. I might do an additional blog post on how I am speeding up the printing process; all this testing would be too tedious if it took me a full day to do one set of separations.
There are, of course, pretty blatant color problems here. The banana leaf in the middle (that’s what it is, in case you hadn’t recognized it) suffers from a severe case of magentitis (I made that up, sorry): way too much magenta. But in my previous post, I already noted the apparent balance issue with too much magenta in the color checker, so no surprise it also materialized here. It was kind of a surprise how bad the issue was, though! Wow. Then there are all sorts of curve problems, resulting in an odd contrast range. We’ll settle that, at some point, I think. And evidently, there’s a bit of a problem with the primaries. I included the primary color gradients for testing purposes, but they also illustrate an inconvenient reality here: the real world ‘magenta’ looks nothing like the digital magenta, and the same goes for all the others. Even black isn’t actual black, but more of a very deep chocolate brown.
There are two things I could do at this point – and I’ll need to do both. One: adjust the pigment set so that the colors are chosen in an intelligent fashion. We’ll get into that shortly. Two: I need some kind of profiling and soft-proofing approach so that what I make digitally, is translated to color separations in such a way that it matches the (in)capabilities of the printing process. I haven’t tackled #2 yet, although I might get lucky and be in the position to borrow an actual profiler soon!
Back to #1: the pigment set. I had never given pigments much thought, but now I have to. And it’s fun, actually. First let’s see what we’re trying to do.
This is the basis: take two pigments and blend them to make other colors. Since this is printing space, we generally work with 3+1 pigments: cyan, magenta, yellow and added black for neutral, deep blacks. There are of course alternatives and extensions to the process, but let’s keep it at this for a moment. Additional spot colors are great, but something I’ll sidestep until I have a firmer grip on the basics. In theory, the combination of three colors that are sufficiently far apart from each other on the color wheel should be able to make all imaginable hues by blending them. Right? Well, not quite. Here’s that color wheel (the CIELAB version at least):
In the circle above, all hues are represented and I’ve indicated the position of the primaries Cyan, Magenta and Yellow (at 225, 315 and 90 degrees). You might also notice that there’s considerable distance to the outside diameter of the circle and its center. In other words: it’s actually a circle, not a dot. The distance from the center of the circle to any point within the circle is the chroma of a hue: it indicates how saturated it is. Hues very close to the center have a low chroma and are closer to the greyscale than to the colorful outside rim. Hues that are closer to the outside rim are more saturated and colorful. This is also why I put the primaries on the outside rim: they’re at the highest theoretical level of chroma – they’re after all mostly theoretical constructs anyway. So these two characteristics, hue (which color is it?) and chroma (how saturated is this color?) turn out to be important considerations in which pigments we’ll choose for our printing process.
This immediately brings us to a realization: those theoretical values of Cyan, Magenta and are nice, but how do they relate to our real-world colors? Here’s another version of our color wheel, but this time I included a triangle. The three points of the triangle correspond with the pigments that I used for the prints above. I used three paints: for cyan, I used a Winsor & Newton Primary Blue gouache. This is based on the PB15 pigment and I suspect it’s closer to the Red Shade than the Green Shade PB15:3 pigment we’ll come back to later. For magenta, I used a Talens Permanent Rose Magenta gouache, which is a dual pigment mix consisting of PV19 and PR122 (these are fairly close to each other in the color wheel). For yellow, I used Van Gogh (which is also Talens) Transparent Yellow Medium, which is a PY128 pigment. For the PY128 I had to take a stab at where it is in the color wheel. I suspect it’s pretty close to 90 degrees hue angle and quite likely pretty darn high up in chroma as well. I think I put it a bit low where it is; chroma might even be higher. Anyway, here’s what it looks like on the color wheel:
Now, in the pale yellow triangle I drew, I have simplified something to the point of being dangerous, but it’s sort of good enough for an approximation, for now: I’ve drawn straight lines between the pigments as they are located on the color wheel. Why is this dangerous? Well, the triangle effectively encompasses all hues that can be made by mixing the pigments in various ratios. Consequently, any hue outside this triangle is simply impossible to be made by mixing these pigments. This is called the ‘saturation cost’ of mixing colors.
If I mix a green by throwing some PB15 and some PY128 together, I end up somewhere on the straight line between them – which happens to be very close to the center of the circle. In other words: I end up with green, but it’s muted green that has low saturation or chroma. At least, in theory. In practice, this isn’t entirely correct: sometimes, you can actually get a bit more out of a mix in terms of saturation – or a bit less. In terms of the triangle: the lines aren’t straight, but they’re actually curved. How much, in what angles etc. – I guess only actual testing can figure that one out.
Remember that triangle – it’s the gamut of all hues that we can print with our pigment selection. As you can see, the gamut of my first pigment set should do a pretty neat job at rendering reds, some violets and oranges, and blues and yellows will do just fine. One thing my gamut doesn’t do particularly well, is greens, teals and limes. Pretty much anything to the left side of the color wheel is something I cannot really do very well with these pigments. Is that bad? I don’t know. Look at the little picture of the green Martian alien earlier. It was made by mixing some cyan/blue and yellow that are very close to the ones in the triangle above. Still, it gives a fairly decent green. And then there’s the photo of the banana leaves. Those leaves to the left and right of that image are pretty green, aren’t they? They sure are. But not a particularly vibrant green, and certainly not as vibrant as in the digital original (don’t be fooled by the left image simply being darker – that’s not what I mean. The green is actually less of a toxic, eye-watering green than it might have been). That may have in part to do with how I overlayed the key/black layer on top of the color layers, but it’s also due to the harsh reality of the gamut as I created it. Unwittingly, but hey, I learn!
Up to this point, I had basically been selecting paints/pigments by following my usual ‘seat of the pants, let’s wing it and how hard can it be’ approach that I take early on in a project, until I hit my head hard enough to kick the grey matter into gear. I mostly used Calvin Grier’s (thewetprint.com) pigment selection, which I gleaned from is Gum Printing book. If it’s good enough for him, it sure is good enough for me. After learning some more about it, I still think so. But I now understand much better why it is so. I like that feeling. It also helps me to envision alternatives. Grier’s approach is excellent. And there are other approaches that are interesting as well. He explores them himself as well, as evidenced by his more cent work with spot colors and earth pigments. So let’s have a look at that Calvin Grier pigment selection.
(By the way, if you wonder, why not just get his color pastes and be done with it? There’s several answers to this, which vary from “my local store doesn’t stock them and I like to buy local when I can” to “why ship stuff halfway across Europe if I may get something similar around the corner” to “he’s sold out on magenta” (he is at the time of writing; not an excuse for yellow and cyan, of course) to “what gives that he’s got a wheel that’s round, I can make a wheel too and even if it’s not round, it’ll be my wobble and I happen to like a little wobble to my ride.” It all boils down to “just let me do it my way and when I fail, I can buy into the existing solution knowing exactly why it’s better in every way.” It’s just fun shopping for stuff and trying it out! Oh, one final thing: Grier’s pigments are way cheaper than getting watercolors. Trust me, he’s not lying on that part. In fact, if anything, he’s understating this!)
Grier selected after ample testing for himself the following pigment set: for Cyan, he uses PB15:3, which is beta copper phthalocyanine. The “:3” addition is important, as the PB15:3 pigments lean towards green (and thus cyan, as they’re basically blue to begin with), whereas :0, :1 and :6 lean towards red. For Magenta, he prefers PR122, which is quinacridone magenta. For yellow, he uses PY155, a benzimidazolone pigment. For magenta and cyan, I linked to the excellent pages of handprint.com (Bruce MacEvoy) who has taken it upon himself to write and test just about everything concerning watercolors, with a high emphasis on color and pigments. But it so happens that he’s apparently not omnipotent, and I cannot find anything about PY155 on his website. I therefore assume (the mother of all fuckups…) that PY155 is pretty close to PY151 and PY154 (also yellow benzimidazolones, and pretty darn close on the color wheel) in terms of hue and chroma. Why Grier didn’t just pick either PY151 or PY154, which seem to be more common? It may have something to do with staining, transparency, toxicity or dispersion stability. If I were to make an educated guess, I’d say it’s probably staining. You’ll have to ask him. Anyway, let’s see what the gamut of this Grier/thewetprint pigment set looks like:
There’s a clear difference concerning the yellows, but I’m not sure this is meaningful. I assumed that Grier’s PY155 is close to PY155; I’m quite confident this is pretty much correct. I also assumed that PY128 that I used is ‘somewhere up there as well’. This is much more uncertain. In fact, I suspect that PY128 is probably very close to PY154/155 and that consequently this difference just isn’t very meaningful.
In terms of the magenta, we both used PR122, but mine was mixed with P19. Because PV19 is very close to PR122, I don’t think it necessarily impacts the gamut all that much. But for one thing: we assumed earlier that the lines between the pigment positions are straight, but also established this assumption isn’t accurate. I can very well imagine that a PV19/PR122 mixes in a different way with other hues, and that this difference might in fact result in the gamut being smaller than if a pure PR122 is used. Or maybe the opposite? I just don’t know, but I’m pretty sure it does something. So there is some kind of difficult to quantify difference here.
Then there’s cyan, or rather the blue side of things. I suspect my mix uses one of the other PB15’s, such as PB15:1, which is more red than Grier’s PB15:3. This should impact the Achilles’ heel of both gamuts: the green side. There’s probably a reason why handprint.com dedicates a lengthy page all to the problem of mixing greens! I have yet to read, let alone comprehend, all of it, but I do presume from this that the slight shift of PB15:3 towards green as opposed to the more red-leaning PB15:1 c.s. will be meaningful in this regard.
Concluding then that Grier’s pigment set at the very least has clear merits, and probably is superior to what I ended up buying, can we then translate his set into a shopping list of watercolors I can take to my local shop? Again, I could buy Grier’s pigments, and there’s a good chance I’ll end up doing that at some point as well (sans the magenta, which has run out; I came too late to the party for that one!) Well sure, I could. And it would go something like this (numbers between bracket are the brand’s watercolor identification number):
- Cyan: pigment PB15:3, hue angle at around 250-260 degrees
- Winsor & Newton ‘Winsor Blue Green Shade/GS’ (207 or 707)
- Schmincke ‘Helio Cerulean’ (479)
- Daniel Smith ‘Phthalo Blue’ (053) – although it might be a slight tad too red
- Magenta: pigment PR122, hue angle at around 0 – 10 degrees
- Winsor & Newton ‘Quinacridone Magenta’ (545)
- Schmincke ‘Purple Magenta’ (367)
- Daniel Smith ‘Quinacridone Lilac’
- Yellow: pigment PY154, hue angle at around 85-95 degrees (we take this as a substitute for PY155 as PY154 is common in watercolors, whereas PY155 doesn’t appear to be used much, or at all in this application)
- Winsor & Newton ‘Winsor Yellow’ (058)
- Schmincke ‘Pure Yellow’ (216)
- Daniel Smith ‘Azo Yellow’ (but this is the closely related PY151 instead of PY154 or PY155) or ‘Lemon Yellow’ (which has PY175, again a closely related bennzimidazolone yellow, but it appears to have a somewhat lower chroma than the others)
I actually ordered a kit of Winsor & Newton tubes along the lines above to see how I like it. Testing can be fun – as long as it doesn’t run out of hand.
But, speaking of which…if we can figure out why a certain gamut may work, and how to translate it into a shopping list, could we also figure out an alternative to the solution above? Well, I suppose we could. After all, how hard can it be?
Taking as a starting point two things I don’t feel quite comfortable with in the present solution: the magenta isn’t really magenta, and the cyan isn’t really cyan. For a CMYK set, those two concerns sound pretty plausible, right? Well, in fact, I doubt these concerns are so grave. For instance, look at inkjet inks. Both PB15:3 and PR122 are quite commonly used in inkjet inks, at least as far as I can glean from whitepapers and patent applications. Surely, other blue(ish) pigments are also used, but at least PB15:3 seems to have its merits (page 7, bottom). Likewise, PR122 is a common occurrence in the same application field, so apparently, other people with far more knowledge than I have in this area do not really share my concerns. Still, let’s see where we end up if we tackle these (non-)issues.
For starters, let’s look at an alternative to PR122. As said, it’s a bit too red to be a true magenta, so what could we find in the actual magenta corner? Looking at the very nice chart on handprint.com, there’s an interesting set of pigments at the bottom right we could investigate. Some of those, such as PV16, PV23 and PV15 (RS) would be interesting, if not for the fact that they’re a bit too close to the center of the circle. In other words, they have only a moderate chroma or saturation. Since we can never mix our way out of a low saturation situation (the opposite, however, is possible), I’d like our primary pigments to be as saturated as possible. This leaves us with something like PV49 (Cobalt violet). Alright, doesn’t seem to be popular, but at least Daniel Smith appear to have a paint based on it, so that makes it feasible.
Then the other one, the cyan part. Just like the magenta segment, the cyan segment does not appear to be very densely populated. Discarding the candidates of low chroma, we end up with something like PG50 (Cobalt teal blue), which happens to be a popular one. Like PV49, it has excellent light-fastness, so it won’t fade much. Now, PG50 comes in a couple of forms that range from something closer to green to something closer to blue. It so happens that the greener shades are also of lower chroma, so instead I’d select something closer to blue – although the greener shade would be interesting as it should contribute to better rendition of green hues. If that is desirable, we could also lean towards PG7 (Phthalo green blue shade), although it has a bit lower chroma than the blue-leaning PG50’s.
For yellow, I simply don’t see anything wrong with the PY154 we already found; it’s a true yellow, it has very high chroma and pretty much no horrible downsides. Why fix something that’s not even close to being broken?
So our alternative pigment set could be like this:
I don’t really know if the gamut of the alternative set will necessarily be bigger. It depends a lot on how the colors mix, I suppose. There’s probably a reason why the extant pigment sets for inkjet inks seem to lean heavily (or virtually exclusively) on PB15:3 – a reason I don’t know (yet), but that someone who’d try this alternative set would probably find out the hard way! So for the adventurous among us, here’s a shopping list attached:
- Cyan: PG50 (Cobalt teal blue) or PG7 (Phthalo green blue shade)
- Winsor & Newton ‘Cobalt Turquoise Light’ (191; PG50) ‘Winsor Green Blue Shade’ (719; PG7)
- Schmincke ‘Cobalt Turquoise’ (509; PG50)
- Daniel Smith ‘Cobalt Teal Blue’ (PG50)
- Magenta: PV49 (Cobalt violet)
- Daniel Smith ‘Cobalt Violet’
- Yellow: PY154 (Benzimidazolone yellow)
- Winsor & Newton ‘Winsor Yellow’ (058)
- Schmincke ‘Pure Yellow’ (216)
- Daniel Smith ‘Azo Yellow’ (PY151 instead of PY154) or ‘Lemon Yellow’ (PY175 instead of PY154)
As seen above, in this pigment set, the magenta is a bit of an oddball and indeed it seems to be a rare beast in watercolor pigments. Why? I just don’t know. I do understand there are only one or two suppliers of the pigment, and perhaps paint manufacturers would rather lean towards pigments that are easier to source than to become dependent on a single source, resulting in relationship tension at some point in time. Pure conjecture on my part; it might just as well be the case that PV49 is difficult to disperse or something like that.
Oh, did I say adventurous? Well, did I also mention that in my order of some paints to try out, I actually did include some Winsor & Newton ‘Cobalt Turquoise’ and some Daniel Smith ‘Cobalt Violet’? I’m not saying I will try it, but you know, if the opportunity arises, I just might…

domain: artistic


text:
Very few AAA games series stand the test of time. Even former stalwarts like the Settlers end up either retiring outright or becoming online-only clickers. Others, however, get a second lease of life when they are revived. Doom, Wolfenstein, and others have gained a second lease on life. Normally this is from either fans reviving the IP or companies dusting off their back catalog. There are some now who can stand to gain from the introduction of VR into the mainstream. Here are the AAA games candidates that will gain a lot from a VR experience.
Ace Combat is a series that’s been around since the heyday of arcades. An interesting mix between simulator and arcade, you fly as a fighter pilot in a fictional world. The action is fast-paced and exciting, and even though the latest installments have all been subject to dumbing down for either mobile audiences or those not used to flight sims, the series is still going strong with the release of Ace Combat 7 next year. VR would be an excellent compliment to the series because it gives the extra immersion of being in a fighter jet and removes the common issue with VR, extreme nausea. Thankfully Namco Bandai thinks the same, and there will be support for the PSVR with the next installment. However, the VR content is separate from the main story. If VR picks up, maybe the title afterward will make a move to full VR content.
Another entrant in the list who is actively working on a VR experience, Resident Evil has had an identity issue for a long time. Since RE4, Capcom’s iconic horror franchise has seen some questionable entries. With the release of RE7, it seems like the feel of the original has been recaptured. This is also the first entry in the franchise to experiment with VR, which has so far received mixed responses. However, we have been shown that VR horror is very effective. If Capcom can work to remove all of the kinks, Resident Evil VR could be a triumph, and revitalise horror AAA games.
Timesplitters is an entry that is perfect for VR for many reasons. It’s an on-rails shooter, which works great in arcades but less so for home consoles. However, in VR that’s perfect because we haven’t found a solution to the problem of moving around in VR without inducing nausea. So playing a game where all you do is pop out of cover and shoot at bad guys can fill that uneasy gap that has been created with FPS games in VR. Since there are already shooters that emulate the Time Crisis experience, the time is right to move this arcade shooter to the home console in a way that makes sense.
System Shock and its sequel are often lauded as some of the best games ever released. Bioshock, while not quite reaching that, is a fantastic game which balances atmosphere, narrative, and gameplay which very few manage. But, since Irrational Games closed up shop after Bioshock Infinite, we have not seen any new entries into the franchise. Maybe it’s time to return to this world? After all, the only way to improve upon the world of Rapture or Columbia is the ability to see it in VR.
All the fun of a racing sim without the tiresome limitations like traction or g-forces, and you would have F-Zero. This cult classic racing game is crazy, and in desperate need to returning to this generation of consoles. Just like with Ace Combat, this is a title that would be perfect for VR, sitting you in a cockpit of what is essentially a rocket running around a race track. Experiences like Rogue One’s X-wing experience and the VR Jackal section of Call of Duty: Infinite Warefare have shown the appeal of cockpit-oriented VR experiences, so let’s bring F-Zero Back in this form.

domain: hobby


text:
I would definitely use something like this for my music video, i love the idea of an abandoned building and the mystery behind it. I would use low key lighting if i included a an abandoned building in my video.
15 Sculptures Made from Old Watch Parts from Susan Beatrice. The designs are created with the environment in mind. Recycled, upcycled and repurposed objects are combined with natural elements into unique, Earth-friendly items.
Edward Robert Hughes - Midsummer Dream c.1908 - “The Faeries went from the world, dear, because men’s hearts grow cold, and only the eyes of the children see what is hidden from the old and only the majick of love, dear, can ever turn the key that unlocks the gates of Fae and set the Sidhe free.” —Unknown
Artist Maurice Mbikayi explores the effects of technology on identity and history, as well as how it has impacted Africa both positively and negatively. His art combines recycled materials such as old keyboard parts to telephone cords
#nomorolemodel Beatrix Potter (1866-1943) was an English author, illustrator, natural scientist, and conservationist best known for her children's books such as those in The Tale of Peter Rabbit (1901), which she wrote for the five-year-old son of her governess. She was happily married but the couple were childless. Beatrix's conservation efforts and generosity were a key factor in the creation of the Yorkshire Dales National Park. Her home 'Hilltop' is now owned by the National Trust.


text:
Leather Bag Handmade of Nubuck in Nude-Pink “Clio” Medium
Cross-body bag handmade of fine quality nubuck leather in nude-pink.
Clio design features our signature chain shoulder strap with gold hardware.
It’s the perfect size for storing your cell, wallet and make-up essentials.
- Additional information
- Size: Height 17 cm (6.7 inches) – Width 24 (9.4 inches) – Depth 4.5 cm (1.8 inches)
- Detachable strap: 106 cm (41.7 inches)
- Magnetic snap closer
- Without lining
Handmade to order – Ready to be shipped in 1-2 weeks

domain: design


Actress Anu Emmanuel started promotions for her latest telugu film Shailaja Reddy Alludu. Shailaja Reddy Alludu stars Akkineni Naga Chaitanya and Anu Emmanuel in the lead roles. The film also stars Ramya Krishnan in an important role. The film is directed by Maruthi and music was composed by Gopi Sundar.
Check out the latest stills of Anu Emmanuel From Shailaja Reddy Alludu Promotions


text:
We noticed that you're using an unsupported browser. The TripAdvisor website may not display properly.We support the following browsers: Windows: Internet Explorer, Mozilla Firefox, Google Chrome. Mac: Safari.
i had a stay in Prague for a couple of days, I was at this hotel
it was very nice place, small hotel, nothing big and luxurious, therefore i was moreorless satisfied, good price for the services they offer
rooms - nothing special, it has...More
- No fridge in the room
+Excellent location near to public transport and 20 minutes walking distance to the historical center. Lovely neighborhood with plenty of restaurants/bars. Nice park just next door. Very helpful receptionists, good breakfast, room was clean and had separate rooms for...More
Quiet area with lots of cafes,wine bars,& restaurants....easy walk to the more touristy area...Stayed in a Airbnb but there are many hotels...The church is lovely...nice little pubs..Pivovarsky Klub was a great on with 250 beer & traditional czech food..
In a 'nut shell'?...hassle-free/friendly reception, clean room/bathroom/bedding, excellent breakfast safe area, convenient distance from tourist sights (old town - 20-25 mins walk).
This 3* hotel does exactly this, and does it well. Check-in/out was friendly (especially Diana and Areena?), hassle-free (no 'games'/superfluous charges), efficient...More
I really liked my stay there - the hotel is perfectly located within a walking distance to the city centre (about 3 km). You can also go by underground or by tram. Breakfast is fine - I liked the selection of food. Our room was...More

domain: travel


text:
Use listing coloring pages and one of those crayon methods for your following classroom art lesson.
Trace over the photocopied picture outline with crayon.
Thick lines work most effectively.
Brush on the whole page with thin paint. Only use one color.
The waxed lines will resist the paint and also the picture will glow through.
Color the majority of the picture with crayon. Leave some areas white.
Brush over the whole page with thin paint. Only use one color.
Draw over the lines with crayon.
Paint the image with many colors.
The crayon lines will make the photo easier to paint.
They will eradicate edges bleeding into the other.
This is not a resist but it’s an excellent extension of the previous activities.
Paint the image with watercolors.
When the paint is dry, use crayons to incorporate detail and depth of color.
Rip off a smaller notepad that is concerning the size of a matchbox.
Use a crayon to scribble thickly on the paper.
Turn the paper over and taking advantage of your thumb rub the crayon on to the photo.
This results in a very soft smooth effect.
Color a place of the photo with a textured object placed underneath.
Sandpaper, string, crumpled paper, bricks, bark, leaves, signs and rocks can produce interesting patterns. Experiment with a part of blank paper first.
Use grated pieces or shavings of crayon to produce a swirling effect.
Sprinkle the crayon on to the picture after which rub them with your thumb.
This is useful if you use different colors together.
It makes effective animal fur, storm clouds or grass.
Go over the outline of the image with black crayon.
Color the remainder of the picture thickly with crayon.
If possible use a smaller piece of cotton wool or cloth to polish the picture.
Heat from the friction of rubbing melts the crayon and generates a smooth shiny effect.
Apply a little amount of vegetable oil to your cotton wool ball.
Gently rub the oil in the back of the picture.
The oil will make the photo almost transparent.
Students could be due to the oil soaked balls inside a paint tray.
Encourage these phones go over and on the picture to spread the oil.
Hang the image in the classroom window to create a stained glass effect.


text:
Microsoft is releasing a phone application platform for emerging markets — South Africa is first — that will let owners of so-called “feature phones” (non-smartphones) run some smartphone apps by hosting them in the cloud.
Called OneApp, the platform has both client and server components. The client code that runs on the feature phone is tiny, only 150 KB. The server components run as “cloud services that help offload processing and storage from the phone to the Internet, improving overall performance,” according to Microsoft (NASDAQ: MSFT) statements.
Feature phones make up the majority of the most popular mobile phones used in emerging markets. However, while they may have some smartphone-type features, such as a built-in camera, FM radio, and browser, they generally lack the memory and processor power, as well as an operating system, capable of running more demanding smartphone applications.
OneApp aims to change that.
In South Africa, OneApp will be available through Blue Label Telecoms as part of the upcoming release of the operator’s mibli consumer mobile service.
On the list of apps that feature-phone users can run are Facebook, Twitter, Windows Live Messenger and Mobile Wallet. However, what applications will actually run on which operator’s feature phones “will vary by partner,” Microsoft’s said. For instance, South Africa’s mibli service will include a mobile wallet, Windows Live Messenger, popular games, and multiple feed readers for sports and news as well as finance.
OneApp runs on most feature phones that support Java. On the list of feature phones that work with OneApp initially, are numerous models by Nokia (including the 3555, 5320, E50, N70 and others) and Sony Ericsson (including the C510, C902, G705, K610i and others) as well as the Samsung U900.
Broader release and developer kit coming next year
While OneApp will see the light of day first in South Africa, Microsoft has plans to deploy it in other emerging nations in the next year. Microsoft also plans to have a developers kit out for OneApp by the end of 2009.
The Unlimited Potential Group “is tasked with creating new business models and technology solutions tailored specifically for the needs of customers in underserved communities” around the world, UPG said in a Microsoft statement.
Article courtesy of InternetNews.com.

domain: news


text:
Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trial
Trials volume 17, Article number: 18 (2016)
Previous psychological and pharmacological interventions have primarily focused on depression disorders in populations with cardiovascular diseases (CVDs) and the efficacy of anxiety disorder interventions is only more recently being explored. Transdiagnostic interventions address common emotional processes and the full range of anxiety and depression disorders often observed in populations with CVDs. The aim of CHAMPS is to evaluate the feasibility of a unified protocol (UP) for the transdiagnostic treatment of emotional disorders intervention in patients recently hospitalized for CVDs. The current study reports the protocol of a feasibility randomized controlled trial to inform a future trial.
This is a feasibility randomized, controlled trial with a single-center design. A total of 50 participants will be block-randomized to either a UP intervention or enhanced usual care. Both groups will receive standard CVD care. The UP intervention consists of 1) enhancing motivation, readiness for change, and treatment engagement; (2) psychoeducation about emotions; (3) increasing present focused emotion awareness; (4) increasing cognitive flexibility; (5) identifying and preventing patterns of emotion avoidance and maladaptive emotion-driven behaviors (EDBs, including tobacco smoking, and alcohol use); (6) increasing tolerance of emotion-related physical sensations; (7) interoceptive and situation-based emotion-focused exposure; and (8) relapse prevention strategies. Treatment duration is 12 to 18 weeks. Relevant outcomes include the standard deviation of self-rated anxiety, depression and quality of life symptoms. Other outcomes include intervention acceptability, satisfaction with care, rates of EDBs, patient adherence, physical activity, cardiac and psychiatric readmissions. Parallel to the main trial, a nonrandomized comparator cohort will be recruited comprising 150 persons scoring below the predetermined depression and anxiety severity thresholds.
CHAMPS is designed to evaluate the UP for the transdiagnostic treatment of emotional disorders targeting emotional disorder processes in a CVD population. The design will provide preliminary evidence of feasibility, attrition, and satisfaction with treatment to design a definitive trial. If the trial is feasible, it opens up the possibility for interventions to target broader emotional processes in the precarious population with CVD and emotional distress.
ACTRN12615000555550, registered on 29/05/2015
Depression disorders are severely disabling and common in cardiovascular disease (CVD) populations and portend poorer cardiovascular outcome [1, 2] and high costs . Consequently, the treatment of depression disorders has dominated the contemporary psychological intervention landscape in populations with CVD for the past 25 years. Considering that depression is a putative CVD risk factor that is also modifiable, a common hypothesis is that psychosocial interventions in this population would lead to significant benefits to an otherwise poorer cardiovascular prognosis. However, prior intervention efforts addressing depressive symptoms among CVD patients have not typically produced a sizeable clinical impact upon either depression or major CVD morbidity , and these unsatisfying findings raise the question of how existing interventions could be improved.
Several lines of evidence indicate that interventions focusing solely on depressive symptoms in CVD patients may be too narrow in focus. Specifically, an accumulating body of work shows that anxiety disorders confer CVD morbidity risk independent of or in conjunction with depression [5–14]. Indeed, the clinical reality of comorbid depression and anxiety that is evident in CVD populations  closely parallels findings in clinical and epidemiological samples [16, 17]. Nonetheless, the heightened CVD risk is not constrained to simply depression and anxiety disorders given that positive associations between CVD events have been reported in relation to hostility, anger, stress, social isolation, worry, rumination, somatic depressive symptoms, anxiety sensitivity, phobic anxiety and the specific combination of negative affectivity and social inhibition [15, 18–22]. Collectively these findings point to the likelihood that common processes underlying negative emotions generally also portend CVD risk , raising the possibility that an intervention that transcends diagnostic boundaries and targets core emotional processes would be a step toward improving mental health interventions among CVD populations.
Limitations of the extant depression intervention findings in CVD
Several lines of evidence raise the possibility that interventions focusing solely on depression disorders have been ineffective in the population with CVDs. First, prior controlled efforts to address depression in patients with coronary artery disease [4, 23] and heart failure  via psychological and pharmacological interventions have reported only small, albeit significant, effects on depression symptoms. Strikingly, the effect sizes for depression symptom reduction are markedly smaller in CVD samples than that observed in other chronic diseases such as Type II diabetes samples . Collective findings have prompted a closer examination of the specific therapeutic components of interventions for depression used in CVD samples that might lead to an improved outcome , as well as an exploration of novel methods of mental health service delivery such as collaborative care . Intriguingly, neither avenue of empirical enquiry has consistently yielded moderate or larger effect sizes for depression symptom reduction to date. Likewise, despite initially promising findings from one collaborative care randomized controlled trial (RCT) suggesting a reduction in major adverse cardiac events (MACE) , these findings were not sustained in the longer term [23, 29]. Together, these findings point to the strong possibility that mental health interventions exclusively targeting depression in CVDs are incomplete and too narrow in focus.
Anxiety burden and effects on CVD prognosis
Parallel to what has been reported for depression, an emerging literature has uncovered an association between anxiety with CVD morbidity [8, 15], prompting questions regarding whether depression is a discrete psychiatric risk factor for MACE [11, 15]. Specifically, two recent meta-analyses indicated that post-traumatic stress disorder was associated with a twofold recurrent acute coronary syndrome risk  whereas generalized anxiety disorder (GAD) was associated with a 21 % increase in MACE risk . Although the association between panic disorder and CVD events is tenuous [9, 30–34], panic disorder nonetheless signifies high emergency department utilization for chest pain and diagnostic tests to rule out acute coronary syndromes , representing a major burden on the healthcare system.
Importance of anxiety intervention in CVDs
Alongside depression, the American Heart Association  and the German Cardiac Society  recommend comprehensive assessment of anxiety disorders in CVD patients. In depressed CVD patients, the prevalence of comorbid anxiety disorders is 30 % to 50 % [15, 27]. In addition, 50 % of cardiac patients presenting for psychotherapy meet at least one anxiety disorder diagnosis [37, 38], and higher anxiety is associated with depression treatment resistance . Despite the prevalence of anxiety disorders in CVDs exceeding community estimates  and comparable to depression prevalence in CVD , no clinical guidelines exist for treatment when anxiety disorder comorbidity is present in this population . Moreover, with increasing recognition of the necessity to formulate interventions matching the complexity of CVD populations [37, 41] and the requirement for mental health interventions to match transdiagnostic developments in clinical psychology [42–47], the use of depression disorder-only treatments may become increasingly obsolete.
Previous work supporting the need for a transdiagnostic approach in CVDs
Our recent work supports the assertion that an expansion of mental health interventions beyond depression to incorporate comorbid anxiety disorders is warranted in populations with CVDs. A screen-and-treat model of care for heart failure patients was undertaken in three South Australian tertiary hospitals where we observed that panic disorder and anxiety due to a medical condition was associated with high emergency department utilization . Furthermore, a reduction in CVD readmissions was observed with CBT for GAD . We hypothesized that an intervention focusing on somatic anxiety symptoms led to a significant reduction in CVD hospital readmissions and to an improved depression response .
Despite strong evidence collectively demonstrating how anxiety disorders are common and necessitate treatment in CVDs, a critical absence of interventions with broader reach beyond depression exists, which forms a major oversight in improving upon existing mental health interventions. Therefore, treatment of a broader range of emotional disorders and their common emotional processes likely would be an innovative step toward improving mental health interventions and cardiovascular health among CVD populations. Targeting the most common psychological processes that confer CVD risk with a single set of therapeutic principles would open the possibility for a more parsimonious application of effective mental health interventions to a broader range of CVD patients. Herein, we outline the methodology for a study of this type based on the unified protocol (UP) for transdiagnostic treatment of emotional disorders [42, 44–46].
The aim of the Cardiovascular Health in Anxiety and Mood Problems Study (CHAMPS) is to prospectively study the UP in patients with a recent CVD hospitalization and comorbid depression and/or anxiety. The outcomes of interest include the standard deviation of self-rated depression, anxiety and quality of life symptoms. Other relevant outcomes include rates of EDBs (tobacco smoking and alcohol use), physical activity levels, patient adherence, cardiac and psychiatric readmissions. A third objective is to explore trajectories of emotional distress in relation to EDBs and psycho-behavioral CVD risk factors. The data obtained will provide an estimate of effect size for a larger more definitive trial.
This prospective study is a feasibility randomized controlled trial, of parallel design, comparing the effectiveness of the UP versus enhanced usual care. A total of 50 participants will be recruited from the Queen Elizabeth Hospital, a tertiary hospital in the western urban area of Adelaide, South Australia. Parallel to the main trial, a nonrandomized comparator cohort will be recruited comprising at least 150 persons scoring below the predetermined depression and anxiety severity thresholds. Figure 1 depicts the trial design. The trial will be conducted in accordance with the CONSORT statement .
Inclusion criteria are as indicated below:
Age ≥ 18 years.
A primary hospital admission for CVD (specified by relevant International Classification of Disease codes for coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, other ventricular or atrial arrhythmia, coronary revascularization intervention, symptomatic coronary heart disease including unstable angina pectoris, or heart valve disease).
A MINI International Neuropsychiatric Interview (MINI) diagnosis by randomization naïve assessors of major depression, dysthymia, GAD, panic disorder, agoraphobia, social anxiety/phobia, or post-traumatic stress disorder.
Fluency in English.
Exclusion criteria include the following:
A psychosis or bipolar disorder diagnosis determined by medical history or randomization-naïve assessors.
High suicide risk at psychiatric interview.
Observed cognitive impairment or dementia impeding delivery of psychotherapy or ability to provide informed consent.
Neurodegenerative condition (for example, Parkinson’s disease or multiple sclerosis)
In receipt of GP, psychologist or psychiatrist counselling elsewhere.
A diagnosis of drug and alcohol dependence or abuse determined by randomization-naïve assessors.
Medical condition likely to be fatal within 1 year.
Nonrandomized comparator cohort
Participants scoring below the depression and anxiety severity threshold on the PHQ-9 and GAD-7, and therefore those without any distress, will be part of a nonrandomized comparator cohort. The rationale for the comparator cohort is to answer empirical questions about EDBs, incident emotional disorders and trajectories of emotional distress. Several recent RCTs have adopted a similar approach and recruited a comparator cohort for observational purposes.
Non-randomized comparator cohort eligibility
Age ≥ 18 years.
A primary hospital admission for CVD (specified by relevant International Classification of Disease codes for coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, other ventricular or atrial arrhythmia, coronary revascularization intervention, symptomatic coronary heart disease including unstable angina pectoris, or heart valve disease).
Free from any MINI diagnosis by randomization-naïve assessors of major depression, dysthymia, GAD, panic disorder, agoraphobia, social anxiety/phobia, and post-traumatic stress disorder.
Free from any MINI diagnosis by randomization-naïve assessors or medical history of psychosis or bipolar disorder.
Fluency in English.
The proposed sample for this study was 50 patients randomized to the UP or EUC arm. Parallel to the RCT, 150 persons will be recruited into the nonrandomized comparator cohort. In the total sample (N = 200), incorporation of the nonrandomized comparator cohort (n = 150) and RCT participants (n = 50) will enable us to explore the rates of EDBs, physical activity, medication adherence, hospital readmission and feasibility of a screen-and-treat model of care.
Planned statistical analysis
Data management is outlined elsewhere in our protocol. Comparisons between UP, EUC and the nonrandomized comparator cohort will be made at each follow-up time point on patient level of satisfaction with aspects of psychosocial care. We will evaluate whether screening, education, and support in EUC is a suitable alternative to UP. We will also monitor linkages with primary care to determine whether our suicide risk management strategy is viable when routine depression screening is implemented. These data will help inform the design and day-to-day running of a larger more definitive RCT. In terms of feasibility, we will also evaluate the recruitment eligibility, acceptance, and attrition rates, the length of time taken to recruit, and compliance with the psychosocial questionnaire battery.
In the total sample, incorporating the nonrandomized comparator cohort, the association between EDBs, physical activity, and medication adherence with readmission will be examined. Incident psychological distress and distress trajectories will be evaluated in multi-level models to provide a snapshot of different distress trajectories on each of the measures used in CHAMPS. The longitudinal changes in QOL will also be analyzed in the same manner as incident psychological distress and distress trajectories described above.
An independent statistician will generate the randomization codes. Patients will be block randomized according to a random number generator in alternating block sizes of three and six. Allocation will be concealed in sequentially numbered, opaque, sealed envelopes. Randomization will be stratified by primary CVD admission (myocardial infarction, heart failure, atrial fibrillation, other ventricular or atrial arrhythmia, coronary revascularization intervention, symptomatic CHD including angina pectoris, and heart valve disease) to obtain approximately equal sample sizes in both groups.
Transdiagnostic unified protocol intervention
The UP is a transdiagnostic cognitive-behavioral intervention explicitly designed to address the full range of emotional disorders (anxiety, depressive, and related disorders); this work is done by targeting core, underlying emotional processes that lead to the development and maintenance of symptoms across disorders. The UP is designed for weekly and face-to-face delivery over 12 to 18 sessions. The UP consists of eight modules: (1) enhancing motivation for change and treatment engagement, (2) facilitating better understanding of patients’ emotional experiences, (3) increasing present focused emotion awareness, (4) increasing cognitive flexibility, (5) identifying and preventing patterns of emotion avoidance and maladaptive EDBs, (6) increasing awareness and tolerance of emotion-related physical sensations, and (7) interoceptive and situation-based emotion-focused exposure, and (8) the final module is devoted to summarizing the relevant techniques attained and to developing relapse prevention strategies. A summary of the UP decision tree and intervention outline is shown in Table 1. A more complete description by Barlow et al.  can be found elsewhere regarding the development of the UP and long-term treatment outcomes. An experienced psychologist, who is trained in the UP and trained by the research team on CVDs, will deliver the intervention. In psychotherapy intervention trials, blinding of the study participants, therapists, and study coordinator is not possible. However, all other members of the research team will remain blinded. Intervention fidelity will be maintained by weekly supervision and monitored to determine if the UP requires modification in a larger trial among CVD patients.
Enhanced usual care
Patients randomized to the EUC group will receive an education package delivered by the study coordinator consisting of the beyondblue™ fact sheet regarding anxiety, depression, and coronary heart disease . Participants and their general physician will be informed of the baseline distress results and directed to available clinical services (psychologist or psychiatrist), advising participants to seek assistance for achieving mental wellbeing with the support of their general physician. This conforms to the National Heart Foundation of Australia’s™ guidelines [51, 55]. There are no restrictions on usual care.
Standard of care
All participants will receive standard medical care for CVDs according to international guidelines regardless of the study’s allocation. Standard CVD care includes referral to cardiac rehabilitation, which includes a structured exercise regime, and education about CVD risk factors such as stress, dietary modifications and tobacco smoking cessation. All study participants are permitted to seek psychopharmacology, which will be monitored, from outside the study.
The potentially eligible patients are being identified at the hospital 1 to 4 days after their CVD admission by an authorized hospital staff member employed as a trial coordinator in the cardiology department. A pool of eligible participants will be determined by the trial coordinator’s review of cardiology admissions and medical records if required. In the first instance, persons will be approached on the hospital ward by the trial coordinator and provided with the study information sheet and an opportunity to discuss any aspects of the study with the trial coordinator. The potentially eligible patients are re-contacted by the study’s trial coordinator by letter and then telephone 2 to 8 weeks after their CVD admission. Eligible and consenting participants will provide written informed consent at the baseline appointment. Determination of the depression and anxiety thresholds will be made at baseline. Randomization and patient allocation to trial arms will take place by means of a random number generator prepared in advance by an independent statistician offsite. All participants undergo active monitoring for CVD events and mental well-being (PHQ-9 and GAD-7) through a scheduled phone call every 4 to 6 weeks after randomization. The numbers of eligible and successfully recruited patients will be monitored and discussed on a weekly basis between the CI and trial manager.
Patient rated measures
Psychosocial outcomes will be assessed with a battery of fully validated measures at baseline, after the intervention completion (12 to 18 weeks) and during the 6-month follow-up period. The timing of assessments is shown in Table 2. The self-rated measures will be collected to provide the standard deviation of patient outcomes, which is necessary to perform a power calculation in a larger more definitive trial. Patient rates of alcohol and tobacco use, physical activity, and hospital readmissions will be collected to provide an estimate for a larger more definitive trial.
Anxiety, depression and stress symptoms
Generalized anxiety symptoms will be measured by the 7-item Generalized Anxiety Disorder scale (GAD-7). The GAD-7 severity threshold for clinically relevant symptoms is a total GAD score ≥ 7 . This questionnaire has favorable validity as a tool to identify depression and anxiety disorders in medical patients . The Overall Anxiety and Severity Impairment Scale (OASIS) is a five-item brief measure of anxiety symptoms, avoidance, and severity used in a number of large RCTs . Scores > 8 are indicative of severe anxiety. Depression symptoms will be measured by the 9-item Patient Health Questionnaire (PHQ-9). The PHQ-9 severity threshold for clinically relevant symptoms is a total PHQ score ≥ 10 . Stress will be measured by the Depression, Anxiety and Stress Scales, a 21-item clinical measure commonly used in Australia, validated in adults to age 90 years [57, 58], and in previous studies in the cardiac surgery population [59, 60]. Mild distress for the Stress scale is > 8.
Other rating scales
Quality of life will be assessed with the SF-12. The SF-12 is a commonly utilized and generalizable measure of QOL in CVD populations [61, 62]. Other behavioral factors such as smoking and alcohol use are pertinent to cardiovascular functioning and are likely to be EDBs targeted by the UP intervention. Lifetime and current tobacco use will be measured by items from the Global Adult Tobacco Survey . Recent alcohol use will be measured by the Alcohol Use Disorders Identification Test-Shortened Clinical Version, which provides favorable sensitivity and specificity for the detection of problematic drinking . The physical activity questions from the Australian National Health Surveys are used to classify participants as sedentary or having low, moderate, or high levels of physical activity calculated with metabolic equivalents .
The MINI is a brief structured interview that will be performed by allocation-naïve assessors to determine the primary psychiatric diagnosis and remission at the end of the study [66, 67]. Assessment takes 20 to 40 minutes to complete and has been validated among cardiac patients .
Medical and demographic data
Demographic, comorbidity and CVD condition data will be obtained via project-specific questions. A statewide hospital registry will be used to identify CVD and psychiatric hospital admissions at 6-month follow-up. Major CVD events include myocardial infarction, stroke, coronary revascularization, cardiac failure, and arrhythmia determined with relevant International Classification of Disease Criteria Codes I00-I99 . Admissions for primary psychiatric causes include suicide attempt, deliberate self-harm, and panic disorder (International Classification of Disease Criteria Codes F00-F99) . Electronic data linkage will be used to determine admissions, and adjudication of study outcomes will be performed by an independent panel of cardiologists, blinded to the randomization arm. Patient confidentiality will be maintained.
Intervention acceptability and feasibility
Participants will be asked to rate how effective different mental health care treatments were. The questions will assess psychologist treatments (a component of CHAMPS) and outside treatments: specifically, psychiatrist, GP counselling, anti-depressant, anti-anxiety medications, and other areas of support.
If there are concerns about significant emerging psychiatric symptoms (for example, psychosis, mania or other serious mental health conditions) associated with risks to the participant or others, and particularly if the PHQ score is ≥ 20 or the PHQ-9 item 9 score ≥ 2, the Mental Health Triage will necessarily be contacted, or alternatively, referral to an emergency department will be undertaken if a risk is imminent and high. If significant symptoms or comorbidities (for example, psychosis, hypomania, or substance use) that do not meet the previous criteria emerge at any point during the study, the psychologist will stop the study protocol, treat these conditions and/or provide appropriate referral for psychiatric or drug and alcohol service review. Psychiatric referral should be considered if there are significant risk factors for self-harm or CBT resistance such as personality disorder, past self-harm attempts or treatment-resistant depression.
The study has been approved by Human Research Ethics Committee of The Queen Elizabeth Hospital (approval #HREC/15/TQEH47). Written informed consent will be obtained from the participants before inclusion. Study participants are free to withdraw from the study at any time. The study carries a suicide risk, and therefore, the patients’ levels of suicidal ideation will be monitored with the PHQ-9 (every 4 weeks). As in our real-world clinic, we will follow a protocol for managing suicidal intent and self-harm attempts . An independent data monitoring board will monitor adverse events (cardiac, psychiatric, and other) and report these to the governing ethics board. No plans are made to audit the conduct of the trial until it is completed.
The proposed feasibility RCT intervention for emotional disorders will provide an innovative treatment that potentially better aligns with the complex mental health needs for persons afflicted with CVDs. This is perhaps the first investigation of its kind to comprehensively treat a broad range of emotional disorders in CVDs utilizing a single set of therapeutic principles. If the UP is feasible and acceptable, we will develop a larger more definitive trial, and therefore, the findings may hold relevance for the design of future trials, healthcare service delivery, and funding in cardiology.
Several limitations of this trial exist, including that it is applied to multiple emotional disorders, and potential heterogeneity will exist in the study participants’ treatment needs. In addition, the findings will require replication, perhaps in larger numbers or more homogenous samples.
At the feasibility stage of intervention development, the establishment of superiority of the UP from TAU is important. Definitive identification of the specific components of the active treatment that fosters change in anxiety, depression, and quality of life among CVD patients will not be possible. Moreover, the length of follow-up should be extended in a larger trial to determine the effects on CVD events.
The present feasibility RCT is designed to evaluate the UP targeting emotional disorder processes in a CVD population, with particular focus on acceptability, acceptance rates, satisfaction with care and attrition. If the trial is viable, it opens up the possibility for interventions to target broader emotional processes in the precarious population with CVD and emotional distress and paves the way for a larger more definitive trial. With increasing recognition of the role of negative emotions in CVDs, the need for depression disorder-only treatments could become increasingly obsolete in CVDs as developments in treatments match those in clinical psychology .
The trial has been approved and is currently recruiting.
Cardiovascular Health in Anxiety or Mood Problems Study
enhanced usual care
generalized anxiety disorder
major adverse cardiac event
MINI International Neuropsychiatric Interview
Overall Anxiety Severity And Impairment Scale
Patient Health Questionnaire
quality of life
Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–13.
Samartzis L, Dimopoulos S, Tziongourou M, Nanas S. Effect of psychosocial interventions on quality of life in patients with chronic heart failure: A meta-analysis of randomized controlled trials. J Cardiac Failure. 2013;19:125–34.
Baumeister H, Haschke A, Munzinger M, Hutter N, Tully PJ. Inpatient and outpatient costs in patients with coronary artery disease and mental disorders: A systematic review. Biopsychosocial Med. 2015;9:11.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Coch Data Syst Rev. 2011;9:CD008012.
Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65:62–71.
Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: The Heart and Soul Study. Arch Gen Psychiatry. 2010;67:750–8.
Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS ONE. 2012;7:e38915.
Dao TK, Chu D, Springer J, Gopaldas RR, Menefee DS, Anderson T, et al. Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg. 2010;140:606–10.
Chen YH, Tsai SY, Lee HC, Lin HC. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med. 2009;71:798–804.
Chen YH, Lin HC. Patterns of psychiatric and physical comorbidities associated with panic disorder in a nationwide population-based study in Taiwan. Acta Psychiatr Scand. 2011;123:55–61.
Tully PJ, Baune BT. Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: the German National Health Interview and Examination Survey. Soc Psych Psychiatr Epidemiol. 2014;49:683–91.
Allonier C, Chevalier A, Zins M, Catelinois O, Consoli SM, Goldberg M, et al. Anxiety or depressive disorders and risk of ischaemic heart disease among French power company employees. Int J Epidemiol. 2004;33:779–86.
Scherrer JF, Chrusciel T, Zeringue A, Garfield LD, Hauptman PJ, Lustman PJ, et al. Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J. 2010;159:772–9.
Phillips AC, Batty GD, Gale CR, Deary IJ, Osborn D, MacIntyre K, et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study. Psychosom Med. 2009;71:395–403.
Tully PJ, Cosh SM, Baumeister H. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res. 2014;77:439–48.
Watson D. Differentiating the mood and anxiety disorders: a quadripartite model. Ann Rev Clin Psychol. 2009;5:221–47.
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.
Dreher H. Psychosocial factors in heart disease: a process model. Adv Mind Body Med. 2004;20:20–31.
Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull. 2005;131:260–300.
Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Höfer S, et al. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22:1290–306.
Ladwig KH, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, et al. Position paper on the importance of psychosocial factors in cardiology: Update 2013. German Med Sci. 2014;12:Doc09.
Tully PJ, Winefield H, Baker RA, Winefield H, Denollet J, Pedersen SS, et al. Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study. Biopsychosocial Med. 2015;9:14.
Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Syst Rev. 2014;3:127. doi:10.1186/2046-4053-3-127.
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–37.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus-a systematic Cochrane review. Diabet Med. 2014;31:773–86.
Dickens C, Cherrington A, Adeyemi I, Roughley K, Bower P, Garrett C, et al. Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and meta-regression. Psychosom Med. 2013;75:211–21.
Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. J Am Med Assoc. 2009;302:2095–103.
Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Internal Med. 2010;170:600–8.
Ye S, Shaffer JA, Rieckmann N, Schwartz JE, Kronish IM, Ladapo JA, et al. Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes. Am J Med. 2014;127:1012–6.
Fleet R, Lavoie K, Beitman BD. Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res. 2000;48:347–56.
Katerndahl DA. The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review. J Clin Psychiatry. 2008;10:276–85.
Sardinha A, Nardi AE, Zin WA. Are panic attacks really harmless? The cardiovascular impact of panic disorder. Rev Bras Psiquiatr. 2009;31:57–62.
Walters K, Rait G, Petersen I, Williams R, Nazareth I. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J. 2008;29:2981–8.
Tully PJ, Turnbull DA, Beltrame JF, Horowitz JD, Cosh S, Baumeister H, et al. Panic disorder and incident coronary heart disease: a systematic review and meta-regression in 1,131,612 persons and 58,111 cardiac events. Psychol Med. 2015;45:2909–20.
Wulsin L, Liu T, Storrow A, Evans S, Dewan N, Hamilton C. A randomized, controlled trial of panic disorder treatment initiation in an emergency department chest pain center. Ann Emerg Med. 2002;39:139–43.
Lichtman JH, Bigger Jr JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–75.
Huffman JC, Beach SR, Suarez L, Mastromauro CA, Dubois CM, Celano CM, et al. Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial. Contemp Clin Trials. 2013;36:488–501.
Tully PJ, Wittert GA, Selkow T, Baumeister H. The real world mental health needs of heart failure patients are not reflected by the depression Randomized Controlled Trial Evidence. PLoS ONE. 2014;9:e85928.
Celano CM, Mastromauro CA, Lenihan EC, Januzzi JL, Rollman BL, Huffman JC. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. Psychosom Med. 2012;74:93–9.
Hasnain M, Vieweg WVR, Lesnefsky EJ, Pandurangi AK. Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines. J Psychosom Res. 2011;71:6–12.
Norlund F, Olsson EM, Burell G, Wallin E, Held C. Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial. Trials. 2015;16:154.
Bullis JR, Fortune MR, Farchione TJ, Barlow DH. A preliminary investigation of the long-term outcome of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders. Compr Psychiatry. 2014;55:1920–7.
Gallagher MW, Sauer-Zavala SE, Boswell JF, Carl JR, Bullis J, Farchione TJ, et al. The impact of the unified protocol for emotional disorders on quality of life. Int J Cogn Ther. 2013;6:57–72.
Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: A Randomized Controlled Trial. Behav Ther. 2012;43:666–78.
Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, et al. The unified protocol for transdiagnostic treatment of emotional disorders: Therapist guide. New York: NY Oxford University Press; 2011.
Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders: Protocol Development and Initial Outcome Data. Cogn Behav Pract. 2010;17:88–101.
Sauer-Zavala S, Boswell JF, Gallagher MW, Bentley KH, Ametaj A, Barlow DH. The role of negative affectivity and negative reactivity to emotions in predicting outcomes in the unified protocol for the transdiagnostic treatment of emotional disorders. Behav Res Ther. 2012;50:551–7.
Tully PJ. A good time to panic? Premorbid and postmorbid panic disorder in heart failure affects cardiac and psychiatric cause admissions. Australasian Psychiatry. 2015;23:124–7.
Tully PJ, Selkow T, Bengel J, Rafanelli C. A dynamic view of comorbid depression and generalized anxiety disorder symptom change in chronic heart failure: discrete effects of cognitive behavioral therapy, exercise rehabilitation, and psychotropic medication. Disabil Rehab. 2015;37:585–92.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
Colquhoun DM, Bunker SJ, Clarke DM, Glozier N, Hare DL, Hickie IB, et al. Screening, referral and treatment for depression in patients with coronary heart disease. Med J Aust. 2013;198:483–4.
Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59.
Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, et al. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Client Workbook. New York: Oxford University Press; 2011.
beyondblue: Coronary heart disease, anxiety and depression. Edited by beyondblue, vol. Fact Sheet 18.
Tully PJ, Higgins R. Depression screening, assessment and treatment for patients with coronary heart disease: a review for psychologists. Aust Psychol. 2014;49:337–44.
Campbell-Sills L, Norman SB, Craske MG, Sullivan G, Lang AJ, Chavira DA, et al. Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS). J Affect Disord. 2009;112:92–101.
Crawford J, Cayley C, Lovibond PF, Wilson PH, Hartley C. Percentile Norms and Accompanying Interval Estimates from an Australian General Adult Population Sample for Self-Report Mood Scales (BAI, BDI, CRSD, CES-D, DASS, DASS-21, STAI-X, STAI-Y, SRDS, and SRAS). Aust Psychol. 2011;46:3–14.
Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33:335–43.
Tully PJ, Baker RA, Knight JL, Turnbull DA, Winefield HR. Neuropsychological function 5 years after cardiac surgery and the effect of psychological distress. Arch Clin Neuropsychol. 2009;24:741–51.
Tully PJ, Baker RA, Turnbull DA, Winefield HR, Knight JL. Negative emotions and quality of life six months after cardiac surgery: the dominant role of depression not anxiety symptoms. J Behav Med. 2009;32:510–22.
Tully PJ. Quality-of-Life measures for cardiac surgery practice and research: a review and primer. J Extra Corpor Technol. 2013;45:8–15.
Muller-Nordhorn J, Roll S, Willich SN. Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart. 2004;90:523–7.
Global Adult Tobacco Survey Collaborative Group. Tobacco questions for surveys: a subset of key questions from the Global Adult Tobacco Survey, vol. 2. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789–95.
Australian Bureau of Statistics. National Health Survey: users’ guide. Canberra, Australia: Australian Bureau of Statistics; 2003.
Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-III-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry. 1998;13:26–34.
Sheehan DV, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Supplement 20):22–33.
Tully PJ, Penninx BW. Depression and anxiety among coronary heart disease patients: can affect dimensions and theory inform diagnostic disorder based screening? J Clin Psychol. 2012;68:448–61.
World Health Organization: International Statistical Classification of Diseases and Related Health Problems 10th Revision Version for 2007 Available online at http://www.who.int/classifications/apps/icd/icd10online/. 2007. Accessed 15 Apr 2015.
The authors wish to thank Marilyn Black and Marg McGee for their assistance with CHAMPS. This study is supported by a Vanguard grant from the National Heart Foundation of Australia and a Menzies Foundation Allied Health Scholars start-up grant. PJT is supported by the National Health and Medical Research Council of Australia (Neil Hamilton Fairley--Clinical Overseas Fellowship #1053578). The article processing charge was funded by the Open Access publication fund of the Albert Ludwigs University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no other conflict of interest or competing interests to declare.
The authors declare that they have no competing interests.
PJT, DAT, JDH, JFB, TS, EM, BTB, SS-Z, HB, SC, and GAW contributed to the conception and design of the study. PJT, DAT, JDH, JFB, TS, EM, BTB, SS-Z, HB, SC, and GAW critically revised the manuscript for important intellectual content. PJT, DAT, JDH, JFB, TS, EM, BTB, SS-Z, HB, SC, and GAW made a significant contribution to the research and the development of the manuscript and approved the final version for publication.
About this article
Cite this article
Tully, P.J., Turnbull, D.A., Horowitz, J.D. et al. Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trial. Trials 17, 18 (2016). https://doi.org/10.1186/s13063-015-1109-z

domain: psychology


text:
Varun Tej's upcoming film, Valmiki, has run into a lot of trouble recently. The makers put together a splendid cast and crew for the film, but slowly, there have been issues in the unit with a lot of negativity lingering. Pooja Hegde was the first to walk out of the film, citing issues with her remuneration and misunderstandings with director Harish Shankar. According to sources, Pooja had quoted for a paycheck of Rs 2 crores for a period of just 15 days, which didn't go down too well with the producers. And now, music composer Devi Sri Prasad has found his way out of the team for unknown reasons. Though the makers tried their best to convince him, they were left with the option to go hunting for a new composer.
According to a birdie from the unit, "DSP's exit is definitely bad news for the team. But the producers have now roped in Mickey J Meyer to compose music for the film, and will be making an official announcement on the same very soon."
Varun Tej is having a totally different look for the film, which will steer away from the stylish outfits that he usually sports, opting for a rugged set of costumes.
Valmiki is an official remake of the Tamil hit Jigarthanda, directed by Karthik Subbaraj, who recently delivered a blockbuster with Superstar Rajinikanth's Petta. Though Tamil actor Atharvaa was reportedly brought on board to reprise the role played by Siddharth in the original, there is no official word on it yet.Read More


text:
The Saintly Spiders Sting the Stragglers
The letter Ж from The Anti-Religious Alphabet
14 7/8 x 10 5/8 in. (37.8 x 27 cm)
Mikhail Mikhailovich Cheremnykh
(Tomsk, Russia, 1890 - 1962, Moscow, USSR)
Full Title:The letter Ж from The Anti-Religious Alphabet
Medium and Support:
Marion Stratton Gould Fund
Location: Not currently on view
The Anti-Religious Alphabet
From a portfolio of 27 prints.
The old peasant woman on pilgrimage, a sack on her back and carrying a walking stick, travels along a path that connects at the far right with an enormous spider's web. The spider, his head crowned with the black headdress of a high-level member of the Orthodox clergy, lays in wait. As bait, he dangles religious icons as she approaches the web. Icons like these were purchased by the religious faithful at various pilgrimage sites dedicated to saints and miracles of the Church.


text:
Apr 18, 2014, 11:58 AM EDT
Not official yet, but it sounds as though the New York Islanders are going to keep the fifth overall pick at this year’s draft and send their 2015 first-rounder — a potential lottery ticket to the Connor McDavid-Jack Eichel sweepstakes — to Buffalo as compensation for the Thomas Vanek trade.
Here’s Newsday’s Arthur Staple:
Indications are that the Islanders will hold onto this year’s pick to either select one of the five top prospects who are fairly equally rated, or trade the pick to acquire a more NHL-ready player.
And here’s SNY.tv, passing along a report from a Thursday night fan forum GM Garth Snow attended on Long Island:
Snow, Doug Weight and other Islanders were at Westbury Manor to meet with fans. According to Rob Del Muro, a producer for News 12 who was in attendance, Snow wouldn’t fully commit to retaining the 2014 pick but it seemed like it was a very likely scenario.
Garth wouldn’t 100% commit but said he would “wager any amount of money that they will retain this years first round pick #isles
— Rob Del Muro (@gmen8069) April 17, 2014
The Isles have until June 1 to notify the Sabres whether they’ll surrender this year’s pick, or defer to next year.
- Bishop bounced back in Game 5, but did the Rangers test him enough? 6
- Surging Stamkos: Lightning put Rangers on the brink 16
- Report: Blues will stick with Hitchcock ‘barring anything dramatic’ 14
- WATCH LIVE: Lightning at Rangers, Game 5 of Eastern Conference Final 0
- Kesler on wearing down Chicago: ‘No human can withstand that many hits’ 54
- Video: ‘It’s not the ideal situation,’ says OT hero Vermette of being a healthy scratch 5
- From healthy scratch to hero: Vermette scores OT winner for Blackhawks 60
- Video: Ducks score three goals in 37 seconds to take third-period lead 9
- WATCH LIVE: Ducks at Blackhawks, Western Conference Final Game 4 0
- Cooper on replacing Bishop: ‘That is asinine to me’ 25
- Reports: Sabres thought they had a deal with Babcock, aren’t happy (174)
- Leafs land Babcock with reported 8-year deal, estimated at $50 million (130)
- Russia to be punished for ‘completely out of order’ actions after Worlds final loss to Canada (91)
- Report: Sabres negotiating with Babcock (82)
- What’s wrong with Lundqvist? (70)


text:
SCHOOL-BASED HEALTH CENTER OPENS AT IS 98
Montefi ore Health System held a ribbon-cutting event to celebrate the grand opening of I.S. 98’s school-based health
center earlier this month. The facility’s opening marked the Montefi ore School Health Program’s 31st school-based health
center. Teams of primary care providers, mental health specialists, dentists and community health organizers provide
comprehensive care for over 40,000 children in elementary, middle and high schools throughout the borough.
The ribbon-cutting ceremony of IS 98’s school-based health center. Photo courtesy of Montefi ore Health System
ASSEMBLYMAN BENEDETTO HONORS POST 253
BRONX TIMES REPORTER, NOVEMBER 2 58 9-DECEMBER 5, 2019 BTR
POST 253 DONATES
TURKEYS TO VETERANS’
In preparation of Thanksgiving, the Theodore Korony American
Legion Post 253 recently held a Turkey Drive collecting
monetary donations to purchase turkeys and other items
to donate to the borough’s veteran families living in transitional
housing. Turkeys were donated to 28 families in total.
(l-r) Auxiliary member Joanne Cunningham, past commander
John Lanci, auxiliary president Judy Lanci and Acacia
Network transitional housing director Ravi Rampersaud.
Photo courtesy of the Theodore Korony American Legion Post 253
Turkeys which were handed out to families by the Theodore
Korony American Legion Post 253.
Photo courtesy of Theodore Korony American Legion Post 253
Theodore Korony American Legion Post 253, along with the Ladies Auxiliary, were honored and presented with a proclamation
by Assemblyman Michael Benedetto on Sunday, November 17.
Ladies Auxiliary president Judy Lanci, along with members of the Theodore Korony American Legion Post 253 receive a
proclamation from Assemblyman Michael Benedetto. Photo by Laura Stone
Ladies Auxiliary president Judy Lanci, commander Gene De Francis, fi rst vice chairman Kevin Devine, second vice chairman
Sal Caruso, third vice chairman Nick Tedesco and fi nance offi cer Ed McGee receive proclamation presented by Assemblyman
Michael Benedetto. Photo by Laura Stone


A lucky patron at Nick’s Corner Store, 900 W. Pine St. in Poplar Bluff, has claimed a $100,000 prize on the Missouri Lottery’s recently launched “Powerball/Mega Millions” Scratchers ticket. Butler County resident Bonnie Stewart collected the first of four top prizes available in the $5 game.
“Powerball/Mega Millions” provides players with the opportunity to win up to 20 times on a single ticket. In addition to thousands of prizes ranging from $5 to $100,000, players can also win free Powerball and Mega Millions tickets. The game officially started on Feb. 3.